Scribe Therapeutics
About
Platform
Pipeline
News
Careers
Contact
LinkedIn
Twitter or X
Menu
Close
News + Resources
Keep up with the latest
Featured
This Scientist Is Building Custom Gene-Editing Tools
This Scientist Is Building Custom Gene-Editing Tools
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
CRISPR 2.0, the Next Generation
June 21, 2024
Aspen Ideas: Health
CRISPR 2.0, the Next Generation
June 21, 2024
The Age of CRISPR: Engineering the Future of Genetic Medicine
February 23, 2024
TEDxBerkeley
The Age of CRISPR: Engineering the Future of Genetic Medicine
February 23, 2024
Scribe Therapeutics Picks Cholesterol-Lowering As First In Vivo Gene Target
February 7, 2024
Scrip
Scribe Therapeutics Picks Cholesterol-Lowering As First In Vivo Gene Target
February 7, 2024
All Stories
All
News
Press Releases
News
Exciting new CRISPR-CasX variant could be ‘Swiss army knife’ for genetics
February 5, 2019
Silicon Republic
Read Now
Press Release
Exciting new CRISPR-CasX variant could be ‘Swiss army knife’ for genetics
February 5, 2019
Silicon Republic
Read Now
Previous
News
Future of Epigenetic Medicine
July 22, 2024
FutureBites
Read Now
News
CRISPR 2.0, the Next Generation
June 21, 2024
Aspen Ideas: Health
Read Now
News
CRISPR technology’s next wave: Eight companies to watch in 2024
June 20, 2024
Labiotech
Read Now
News
Top Five Privately Held Gene Editing Therapy Companies
May 31, 2024
Genetic Engineering & Biotechnology News
Read Now
News
Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics
May 22, 2024
Ropes & Gray
Read Now
News
DNA: Cutting the Future of Genome Editing
May 2, 2024
The Biomedical Scientist
Read Now
Previous
Load More
Press release
Scribe Therapeutics Unveils Fully Integrated Platform for Engineering Breakthrough CRISPR-based Genetic Medicines
October 6, 2020
Read Now
Previous
Publications and presentations
Presentation
Scribe Corporate Deck 2025 Q1
February 3, 2025
Read Now
Publication
CasX enzymes comprise a distinct family of RNA-guided genome editors
February 4, 2019
Nature
Read Now
Publication
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
May 1, 2017
Nature Biotechnology
Read Now
Publication
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
March 2, 2017
Nucleic Acids Research
Read Now
Publication
Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
June 1, 2016
Nature Biotechnology
Read Now
Publication
Multi-reporter selection for the design of active and more specific zinc-finger nucleases for genome editing
January 7, 2016
Nature Communications
Read Now
Publication
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
December 15, 2014
eLife
Read Now
Publication
Programmable RNA recognition and cleavage by CRISPR/Cas9
December 11, 2014
Nature
Read Now
Publication
MicroRNA-mediated switching of chromatin-remodelling complexes in neural development
July 30, 2009
Nature
Read Now